ANNUAL GENERAL MEETING IN SCN ELECTS MARIA BORELIUS AS NEW MEMBER OF THE BOARD
(NGM:SCN)
At the Annual General Meeting in Scandinavian Clinical Nutrition i Sverige AB (publ) today, Maria Borelius was elected new Member of the Board.
“I am very pleased to announce that Maria Borelius has been elected new Member of the Board of SCN”, says CEO Ulf Söderberg.
“With her background in journalism, health, science and business Maria has a very interesting profile, and I am looking forward to working together with her.”
”SCN is very positive to having a person with Maria’s experience and competence as a Member of the Board”, says Johan Hessius, Chairman of the Board.
Maria Borelius has a background from the Swedish public service television and radio (SVT and SR), and extensive business and Board experience from publicly traded companies. She has worked internationally as a PR and information consultant for many years, and has written two books in the field of popular medicine. In 2006, Maria Borelius was appointed Minister for Foreign Trade in Fredrik Reinfeldt’s Government.
In addition to Maria Borelius, the SCN Board of Directors are Jörn Erik Aas, Johan Hessius (Chairman), Carl-Gustaf Ingelman and Ulf Söderberg (CEO), all of which were re-elected by the Annual General Meeting.
The following decisions were also made at the Annual General Meeting (AGM):
Proposed Appropriation of Retained Earnings
The AGM decided that the loss for the year be charged against the share premium reserve, and that the retained earnings be carried forward.
Director’s Fees
The AGM decided that the Chairman of the Board is to receive SEK 200,000 in remuneration, and the other Directors not employed by the company are to receive SEK 100,000. The auditor’s fee is to continue to be paid against an approved invoice.
Authorization
The AGM decided to authorize the Board to issue up to 1,063,546 new shares until the next AGM, on one or more occasions, with or without consideration to the pre-emptive rights of the existing shareholders. Issuances shall be done on market terms, with reservation for market rated issue discounts when applicable. Issuances shall be possible to carry out as non-cash issues or on other terms.
Articles of Association
The AGM decided to make some amendments to the Company’s Articles of Association, mainly comprising the following:
· Minor amendments have been made in the article about the Company’s purpose
· A registered auditing firm can be appointed auditor
· The notice of shareholders’ meetings shall be published in Dagens Industri instead of Svenska Dagbladet, and notice respites have been specified
· A requirement to register intention to attend shareholders’ meetings has been adopted
· Determination of the number of Directors and Deputy Directors and, if applicable, Auditors and Deputy Auditors has been brought in as compulsory matters on the AGM agenda
· A possibility to collect Powers of Attorney on behalf of the company in accordance with the procedure set out in the 7th chapter, 4th §, second section of the Swedish Companies Act (2005:551) has been brought in
· Plus minor amendments of editorial nature
For more information, please contact:
CEO Ulf Söderberg, tel +46 708 13 22 81
Scandinavian Clinical Nutrition AB (publ) works in R&D and sales of scientifically documented products within the field of
nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as
CUUR, Membraseven and Ledactin. Core competence and strategic alliances, within both R&D and sales, in combination
with innovative and scientifically documented products, create the right conditions for profitable growth both in Sweden and
in the company’s export markets. The SCN share is listed for trade on NGM Nordic MTF since December 6, 2006.